Hyderabad: The Engineering Export Promotion Council of India on Friday organised an EEPC India roadshow at ITC Kakatiya in Begumpet ahead of the second edition of Pharma MachTech & LabNext Expo 2026.
The event featured interactive sessions on strengthening India’s position as a global innovation hub in pharma machinery and laboratory equipment sectors.
Pharma MachTech & LabNext Expo 2026 will take place from September 7 to 9, 2026, at Bharat Mandapam in New Delhi. In addition, the exhibition will run alongside iPHEX, one of India’s leading global pharmaceutical expos.
The events will showcase the complete pharma and healthcare engineering value chain on a common platform.
Addressing the gathering, chief guest Akshay S.C., Joint Director General of Foreign Trade, Hyderabad Regional Authority, said future growth of India’s pharmaceutical sector depended heavily on the domestic steel and manufacturing industries.
He also stressed the need for manufacturers to align with global market requirements and accelerate indigenous production of specialised machinery.
EEPC India roadshow highlights Pharma 4.0 opportunities
Earlier, EEPC India Executive Director and Secretary Adhip Mitra said India was targeting pharmaceutical exports worth USD 130 billion by 2030.
Therefore, he said manufacturers and exporters needed to focus on value-driven and innovation-led excellence to achieve the target.
Mitra said Pharma MachTech & LabNext Expo 2026 would create opportunities to explore emerging technologies. These include Pharma 4.0, automation, precision drug delivery systems and advanced laboratory equipment.
He added that seminars, conferences and buyer-seller meetings with international delegations would encourage knowledge sharing and global business opportunities.
The organisers also conducted a seminar titled “Transforming Pharma & Biotech Industries through Smart Manufacturing and Next-Gen Laboratory Solutions” during the roadshow.
Rakesh Suraj gave a presentation on Pharma MachTech and LabNext Expo 2026. Meanwhile, industry experts discussed government initiatives, sustainability, digital transformation and advanced manufacturing practices.
EEPC India roadshow underlines Hyderabad pharma strength
The Hyderabad roadshow gained importance because the city contributes nearly one-third of the global vaccine supply and around 40 per cent of India’s bulk drug production.
Engineering clusters in Jeedimetla, Balanagar and Kukatpally continue to support the pharmaceutical engineering supply chain.
India’s domestic pharma machinery sector is currently growing at a compound annual growth rate of 8 to 10 per cent. However, the sector still depends on imports for high-end equipment.
Pharma machinery exports recorded a CAGR of 15.3 per cent during the last five years. At the same time, imports grew by 10.5 per cent, resulting in a negative trade balance.
Similarly, laboratory equipment exports grew at 8.3 per cent CAGR, while imports increased by 7 per cent during the same period.
The programme concluded with a vote of thanks by Arun Shukla, Deputy Regional Chairman of EEPC India. Besides him, Pankaj Chadha, K. Narendran of CDSCO and Suresh Babu attended the event.